Rituximab, MS, and pregnancy

OBJECTIVE: To describe the safety and efficacy of rituximab (RTX) in MS and pregnancy, we conducted a retrospective cohort study of 74 pregnancies among 55 women treated with RTX for MS and their offspring. METHODS: We used prospectively collected information from the electronic health record at Kai...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jessica B., Hellwig, Kerstin, Fink, Katharina, Lyell, Deirdre J., Piehl, Fredrik, Langer-Gould, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217660/
https://www.ncbi.nlm.nih.gov/pubmed/32358226
http://dx.doi.org/10.1212/NXI.0000000000000734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217660/
https://www.ncbi.nlm.nih.gov/pubmed/32358226
http://dx.doi.org/10.1212/NXI.0000000000000734

Ejemplares similares